Talzenna

Generic name: Talazoparib
Dosage form: capsule (0.1 mg, 0.25 mg, 0.35 mg, 0.5 mg, 0.75 mg, 1 mg)
Drug class: PARP inhibitors

Usage of Talzenna

Talzenna (talazoparib) is used to treat specific types of breast cancer.

Talzenna is also used in combination with enzalUTAmide (Xtandi) to treat adults with prostate cancer that is HRR gene-mutated metastatic castration-resistant.

Talzenna works by stopping or slowing the growth of cancer cells. Talazoparib belongs to a class of medications called PARP inhibitors which is the commonly used name for poly (ADP-ribose) polymerase (PARP) inhibitors.

Talzenna is used to treat breast cancer in adults who have deleterious germline BRCA-mutated (gBRCAm) HER2-negative, and it is locally advanced or has spread to other parts of the body.

Your doctor will test your tumor type to make sure that Talzenna is the right treatment for you.

Talzenna was first approved by the FDA on October 16, 2018.

Talzenna side effects

Get emergency medical help if you have signs of an allergic Reaction to Talzenna: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Talzenna may cause serious side effects.

Call your doctor at once if you have:

blood in your urine or stools;

easy bruising, unusual bleeding, purple or red spots under your skin;

weight loss;

frequent infections;

low red blood cells (anemia) - pale skin, weakness, tiredness, feeling light-headed or short of breath, cold hands and feet; or

low white blood cell counts - fever, mouth sores, skin sores, sore throat, cough.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common Talzenna side effects may include

low blood cell counts;

an electrolyte imbalance (such as low blood levels of potassium or magnesium);

bone injuries, low levels of calcium in your blood (hypocalcemia);

high levels of bilirubin in the blood;

high blood sugar;

changes in your sense of taste

nausea, vomiting, diarrhea, loss of appetite;

hair loss;

dizziness, headache; or

feeling weak or tired.

This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Talzenna

To make sure Talzenna is safe for you, tell your doctor if you have or have ever had:

kidney disease.

Using Talzenna may increase your risk of developing bone marrow problems or leukemia. Ask your doctor about your individual risk.

Pregnancy

Talzenna can harm an unborn baby if the mother or the father is using this medicine.

If you are a woman, you may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 7 months after your last dose.

If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 4 months after your last dose.

Tell your doctor right away if a pregnancy occurs.

It may be harder for you to get a woman pregnant while you are using this medicine. You should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.

Breastfeeding

Do not breastfeed while using this medicine, and for at least 1 month after your last dose.

Relate drugs

How to use Talzenna

Usual Talzenna Adult Dose for Breast Cancer

Dose: 1 mg orally once a day until disease progression or unacceptable toxicity. Comment: Select patients based on the presence of germline BRCA mutations as determined by an FDA-approved test. Use: For the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer.

Usual Talzenna Adult Dose for Prostate Cancer

Dose: 0.5 mg taken orally once daily in combination with Enzalutamide, it can be used until disease progression or unacceptable toxicity.

Comment: Select patients for the treatment based on the presence of HRR gene-mutated mCRPC.

Use: For the treatment of adult patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).

Talzenna Capsule are available as 0.1 mg, 0.25 mg, 0.35 mg, 0.5 mg, 0.75 mg, and 1 mg.

Warnings

Using Talzenna may increase your risk of developing bone marrow problems or leukemia.

Talzenna can lower your blood cell counts, and you may get infections or bleed more easily. Call your doctor if you have unusual bruising or bleeding, blood in your urine or stools, weight loss, fever, weakness, tiredness, or trouble breathing.

Your blood will be tested before and during treatment, and your cancer treatments may be delayed based on the results.

What other drugs will affect Talzenna

Tell your doctor about all your other medicines, especially:

amiodarone;

Carvedilol;

clarithromycin;

itraconazole; or

verapamil.

This list is not complete. Other drugs may interact with talazoparib, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.